These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37087413)

  • 1. Correlation of ABO blood groups with treatment response and efficacy in infants with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide.
    Guan Y; Jin Y; Lu Y; Ao D; Gu P; Yang J; Liu G; Han S
    BMC Pregnancy Childbirth; 2023 Apr; 23(1):276. PubMed ID: 37087413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABO blood group is associated with response to inhaled nitric oxide in neonates with respiratory failure.
    El-Ferzli GT; Dreher M; Patel RP; Ambalavanan N
    PLoS One; 2012; 7(9):e45164. PubMed ID: 22984626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn.
    Kinsella JP; Truog WE; Walsh WF; Goldberg RN; Bancalari E; Mayock DE; Redding GJ; deLemos RA; Sardesai S; McCurnin DC; Moreland SG; Cutter GR; Abman SH
    J Pediatr; 1997 Jul; 131(1 Pt 1):55-62. PubMed ID: 9255192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled nitric oxide in the management of persistent pulmonary hypertension of term infants.
    Chen JY; Su PH; Chen FL; Lee HS
    J Formos Med Assoc; 2001 Oct; 100(10):703-6. PubMed ID: 11760378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide for the treatment of preterm infants with severe RDS and pulmonary hypertension.
    Dani C; Corsini I; Cangemi J; Vangi V; Pratesi S
    Pediatr Pulmonol; 2017 Nov; 52(11):1461-1468. PubMed ID: 29058384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting the response to inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn infants.
    Hwang SJ; Lee KH; Hwang JH; Choi CW; Shim JW; Chang YS; Park WS
    Yonsei Med J; 2004 Feb; 45(1):49-55. PubMed ID: 15004868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of hyperoxia during iNO treatment for persistent pulmonary hypertension of the newborn: a cohort study.
    de Jager J; Brouwer F; Reijman J; van der Palen RLF; Steggerda SJ; Visser R; Te Pas AB; Dekker J
    Eur J Pediatr; 2024 May; 183(5):2455-2461. PubMed ID: 38470520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension.
    Cornfield DN; Maynard RC; deRegnier RA; Guiang SF; Barbato JE; Milla CE
    Pediatrics; 1999 Nov; 104(5 Pt 1):1089-94. PubMed ID: 10545552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early risk factors for death in neonates with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide].
    Qian AM; Zhu W; Yang Y; Lu KY; Wang JL; Chen X; Guo CC; Lu YD; Rong H; Chneg R
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 May; 24(5):507-513. PubMed ID: 35644190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled nitric oxide in the treatment of moderate persistent pulmonary hypertension of the newborn: a randomized controlled, multicenter trial.
    Sadiq HF; Mantych G; Benawra RS; Devaskar UP; Hocker JR
    J Perinatol; 2003 Mar; 23(2):98-103. PubMed ID: 12673257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose inhaled nitric oxide for neonates with pulmonary hypertension.
    Tang SF; Miller OI
    J Paediatr Child Health; 1996 Oct; 32(5):419-23. PubMed ID: 8933403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of early adjunctive use of oral sildenafil and inhaled nitric oxide on the outcome of pulmonary hypertension in newborn infants. A feasibility study.
    Al Omar S; Salama H; Al Hail M; Al Rifai H; Bunahia M; El Kasem W; Siddiqui FJ; Dilawar M; Yassin H; Masud F; Mohamed A; Mansour A
    J Neonatal Perinatal Med; 2016 Sep; 9(3):251-9. PubMed ID: 27589542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Inhaled Iloprost for the Management of Persistent Pulmonary Hypertension of the Newborn.
    Verma S; Lumba R; Kazmi SH; Vaz MJ; Prakash SS; Bailey SM; Mally PV; Randis TM
    Am J Perinatol; 2022 Oct; 39(13):1441-1448. PubMed ID: 33477175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of IV Sildenafil in the Treatment of Newborn Infants with, or at Risk of, Persistent Pulmonary Hypertension of the Newborn (PPHN): A Multicenter, Randomized, Placebo-Controlled Trial.
    Pierce CM; Zhang MH; Jonsson B; Iorga D; Cheruvu N; Balagtas CC; Steinhorn RH
    J Pediatr; 2021 Oct; 237():154-161.e3. PubMed ID: 34052232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of endogenous endothelin-1 and inhaled nitric oxide in term and preterm infants.
    Truog WE; Pallotto E; Clark P; Banks B; Kaftan HA; Ekekezie II; Norberg M; Ballard RA
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():294S-297S. PubMed ID: 12193107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants.
    More K; Athalye-Jape GK; Rao SC; Patole SK
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010531. PubMed ID: 27535894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide for respiratory failure in infants born at or near term.
    Finer NN; Barrington KJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD000399. PubMed ID: 17054129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn--a single-center, 5-year experience.
    Gupta A; Rastogi S; Sahni R; Bhutada A; Bateman D; Rastogi D; Smerling A; Wung JT
    J Perinatol; 2002 Sep; 22(6):435-41. PubMed ID: 12168118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled nitric oxide for neonates with persistent pulmonary hypertension of the newborn in the CINRGI study: time to treatment response.
    Nelin LD; Potenziano JL
    BMC Pediatr; 2019 Jan; 19(1):17. PubMed ID: 30636626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhalation therapy with nitric oxide in pulmonary hypertension: Comparison of preterm infants versus newborn infants].
    Schmölzer G; Urlesberger B; Reiterer F; Haim M; Kutschera J; Resch B; Müller W
    Klin Padiatr; 2003; 215(5):257-61. PubMed ID: 14520586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.